written on 22.04.2016

PharmaBoardroom Releases New South Africa Pharmaceuticals Report


Focus Reports releases its new 71 page South Africa Healthcare and Life Sciences Report 2016.

This report offers companies, investors, policymakers, and stakeholders crucial insight into the second-largest economy in Africa; a country embracing globalization with open arms and making significant strides towards reforming its healthcare system.

The report features an exclusive in-depth interview with Dr. Aaron Motsoaledi, South African Minister of Health, as well as with leading figures from both public institutions and private companies. Also included are up-to-date facts and figures on South Africa’s healthcare and pharma sectors.

This report is an authoritative assessment of the South African healthcare and pharma markets. South Africa is significant because of its:

National Development Plan (NDP)

The first nationwide roadmap for South African healthcare; the NDP provides a vision of where the country should be by 2030. It seeks to redress the imbalance of 84% of the population still with only limited access to healthcare.

A Model In Motion

Our 23 page cover story offers crucial insights into South African healthcare and life sciences via interviews with the country’s key opinion leaders. South Africa is serving as an important hub for all of Africa and a vibrant market in its own right.


The South Africa Healthcare and Life Sciences Report 2016 includes features on CSR, Clinical Trials, Healthcare, Regulatory Reform, Medical Devices, Entrepreneurship and Innovation


Key Opinion Leaders in both the public and private sectors have been interviewed to provide the most comprehensive assessment of South African pharma and healthcare currently available.


The report includes interviews with:

  • Dr. Aaron Motsoaledi, Minister of Health
  • Qedani Mahlangu, MEC for Health, Gauteng Province
  • Gaby Simaan Jr, Trinity Pharma
  • Dr. Karsten Wellner, Ascendis Health
  • Tania Zulu Holt, McKinsey
  • Nkaki Matlala, PHEF
  • Mercia Van Zyl, Ferring
  • Anthony Diack, UTi Pharma


  • “For the first time in the history of South Africa, pre and post-apartheid, the country has a clear roadmap under the National Development Plan (NDP), and it has been accepted by all political parties.”

Dr. Aaron Motsoaledi, Minister of Health

  • “If we really look for providing access to quality health care, to the point of universal reach for all South Africans, we have to upgrade and enlarge our current range of services.”

Qedani Mahlangu, MEC for Health, Gauteng Province

  • “Internationalization is important given the imported inflation present in South Africa, due to a weakness of the Rand, which has been devaluating against the major currencies worldwide.”

Dr. Karsten Wellner, Ascendis Health

  • “Because of the duality of our healthcare system, there is still only limited cooperation between public and private sectors.”

Dumisani Bomela, HASA

  • “As the momentum of political resistance against apartheid increased, many white medical graduates left the country, creating an exodus of medical professionals. This put a strain on the healthcare system and, after independence, we did not do enough to fill this gap.”

Nkaki Matlala, PHEF